1-(3-chloro-4-methylanilino)-N-[(1R,2R,3R)-2,3-dimethylcyclohexyl]isoquinoline-4-carboxamide
C25H28ClN3O — CID 92653125
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(3-chloro-4-methylanilino)-N-[(1R,2R,3R)-2,3-dimethylcyclohexyl]isoquinoline-4-carboxamide
1-(3-chloro-4-methylanilino)-N-[(1R,2R,3R)-2,3-dimethylcyclohexyl]isoquinoline-4-carboxamide (PubChem CID 92653125) has the molecular formula C25H28ClN3O and a molecular weight of 421.97 g/mol. Its IUPAC name is 1-(3-chloro-4-methylanilino)-N-[(1R,2R,3R)-2,3-dimethylcyclohexyl]isoquinoline-4-carboxamide.
Molecular Properties
| Compound Name | 1-(3-chloro-4-methylanilino)-N-[(1R,2R,3R)-2,3-dimethylcyclohexyl]isoquinoline-4-carboxamide |
|---|---|
| PubChem CID | 92653125 |
| Molecular Formula | C25H28ClN3O |
| Molecular Weight | 421.97 g/mol |
| Exact Mass | 421.19 |
| IUPAC Name | 1-(3-chloro-4-methylanilino)-N-[(1R,2R,3R)-2,3-dimethylcyclohexyl]isoquinoline-4-carboxamide |
| SMILES | Cc1ccc(Nc2ncc(C(=O)N[C@@H]3CCC[C@@H](C)[C@H]3C)c3ccccc23)cc1Cl |
| InChI | InChI=1S/C25H28ClN3O/c1-15-7-6-10-23(17(15)3)29-25(30)21-14-27-24(20-9-5-4-8-19(20)21)28-18-12-11-16(2)22(26)13-18/h4-5,8-9,11-15,17,23H,6-7,10H2,1-3H3,(H,27,28)(H,29,30)/t15-,17-,23-/m1/s1 |
| InChIKey | IBDDGECDDMPPEI-QDOIMOTRSA-N |
| XLogP | 6.49 |
| TPSA | 54.02 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 421.97 |
| LogP ≤ 5 | 6.49 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 92653125 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.